止血製品の世界市場:産業分析、市場規模、市場シェア、成長、動向、予測

◆英語タイトル:Hemostasis Products Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024
◆商品コード:TMR60924
◆発行会社(調査会社):Transparency Market Research
◆発行日:2016年8月18日
◆ページ数:117
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:産業未分類
◆販売価格オプション(消費税別)
Single UserUSD5,795 ⇒換算¥660,630見積依頼/購入/質問フォーム
Multi UserUSD8,795 ⇒換算¥1,002,630見積依頼/購入/質問フォーム
Corporate LicenseUSD11,795 ⇒換算¥1,344,630見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTransparency Market Research社の日本における正規販売代理店です。Transparency Market Research社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、止血製品の世界市場について調査・分析し、産業分析、止血製品の世界市場規模、市場シェア、成長、市場動向、予測データを含め、以下の構成でお届けいたします。
・止血製品の世界市場:序文
・止血製品の世界市場:エグゼクティブサマリー
・止血製品の世界市場:市場概要・動向
・止血製品の世界市場:セグメント別市場規模・分析
・止血製品の世界市場:地域別市場規模・分析
・止血製品の世界市場:関連企業分析
【レポートの概要】

This report on the global hemostasis products market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments.
The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market size in terms of US$ Mn for each segment for the period from 2014 to 2024, considering the macro and micro environmental factors. Growth rates for each segment within the global hemostasis products market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.
A detailed qualitative analysis of factors responsible for driving and restraining market growth and future opportunities has been provided in the market overview section. This section of the report also includes market attractiveness analysis that provides a thorough analysis of the overall competitive scenario in the global hemostasis products market.
Market revenue in terms of US$ Mn for the period between 2014 and 2024 along with the compound annual growth rate (CAGR %) from 2016 to 2024 are provided for all the segments, considering 2015 as the base year. Market size estimations involved in-depth study of services and product features of different types of services. Additionally, market related factors such as increasing preference for technologically advanced services, product innovation, and growing number of acute and chronic patients in various geographies and historical year-on-year growth have been taken into consideration while estimating the market size.
Based on product type, the global hemostasis products market has been segmented into topical hemostasis products (collagen, oxidized regenerated cellulose, gelatin, and polysacchride), infusible hemostasis products (platelet concentrates from donor blood, FVIII derived from blood, fresh frozen plasma, and prothrombin complex), and advanced hemostasis products (flowable, thrombin, fibrin, and synthetic sealants). The market has been further studied from the point of view of major applications of hemostasis products.
Based on application, the market has been categorized into trauma, surgery, hemophilia, myocardial infarction, stroke, and thrombosis. Based on end-user, the market has been segmented into hospitals and clinics.
Geographically, the global hemostasis products market has been segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Rest of the World. In addition, the regions have been further segmented by major countries from each region. These include the U.S, Canada, the U.K., Germany, Japan, China, Brazil, and Mexico. The report also profiles major players in the hemostasis products market based on various attributes such as company overview, financial overview, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include Abbott Laboratories, Baxter International, Inc., C. R. Bard, Inc., CSL Behring LLC, Grifols, S.A., HemCon Medical Technologies, Inc., Integra LifeSciences Corporation, Johnson & Johnson, Medtronic plc, and Pfizer, Inc.
For this study, the global hemostasis products market has been segmented as follows:
Hemostasis Products Market, by Product type
• Topical Hemostasis
o Collagen
o Oxidized Regenerated Cellulose
o Gelatin
o Polysaccharide
• Infusible Hemostasis
o Platelet Concentrates from Donor Blood
o FVIII Derived from Blood
o Fresh Frozen Plasma
o Prothrombin Complex
• Advanced Hemostasis
o Flowable
o Thrombin
o Fibrin
o Synthetic Sealants
Hemostasis Products Market, by Application
• Trauma
• Surgery
• Hemophilia
• Myocardial Infarction
• Stroke
• Thrombosis
Hemostasis Products Market, by End-user
• Hospitals
• Clinics
Hemostasis Products Market, by Geography
• North America
o U.S.
o Canada
• Europe
o Germany
o U.K.
o Rest of Europe
• Asia Pacific
o China
o Japan
o Rest of Asia Pacific
• Latin America
o Brazil
o Mexico
o Rest of Latin America
• Rest of the World

【レポートの目次】

1. Preface
1.1. Report Description
1.2. Market Segmentation
1.3. Research Methodology
1.4. Assumptions

2. Executive Summary
2.1. Global Hemostasis Products Market Revenue, by Product, 2015 & 2024 (Value %)
2.2. Global Hemostasis Products Market Revenue, by Geography, 2015 & 2024 (Value %)
2.3. Global Hemostasis Products Market, 2015 & 2024: Market Snapshot

3. Global Hemostasis Products Market Overview
3.1. Overview
3.2. Market Dynamics
3.2.1. Drivers
3.2.1.1. Driver 1 – Extensive research & technological advancements
3.2.1.2. Driver 2 – Increasing number of trauma and surgical cases
3.2.2. Restraints
3.2.2.1. Restraint 1 – Stringent regulatory policies
3.2.2.2. Restraint 2 – Patent loss and increasing use of off-label products
3.2.3. Opportunities
3.2.3.1. Opportunity 1 – Emerging market in developing countries
3.2.3.2. Opportunity 2 – Visible pipeline of new products
3.3. Market Attractiveness Analysis: Global Hemostasis Products Market, by Geography, 2015
3.4. Competitive Landscape: Hemostasis Products Market, 2015 (Value %)

4. Global Hemostasis Products Market Revenue (US$ Mn), by Product type, 2014–2024
4.1. Overview
4.2. Global Topical Hemostasis Product Revenue, by Product type, (US$ Mn), 2014–2024
4.2.1. Global Collagen Market Revenue, (US$ Mn), 2014–2024
4.2.2. Global Oxidized Regenerated Cellulose Market Revenue, (US$ Mn), 2014–2024
4.2.3. Global Gelatin Market Revenue, (US$ Mn), 2014–2024
4.2.4. Global Polysaccharides Market Revenue, (US$ Mn), 2014-2024
4.3. Global Infusible Hemostasis Products Revenue, by Product type, (US$ Mn), 2014–2024
4.3.1. Global Fresh Frozen Plasma (FFP) Market Revenue, (US$ Mn), 2014–2024
4.3.2. Global Platelet concentrate from donor blood Market Revenue, (US$ Mn), 2014–2024
4.3.3. Global Factor VIII derived from blood Market Revenue, (US$ Mn), 2014–2024
4.3.4. Global Prothrombin complex Market Revenue, (US$ Mn), 2014–2024
4.4. Global Advanced Hemostasis Products Revenue, by Product type, (US$ Mn), 2014–2024
4.4.1. Global Flowable complex Market Revenue, (US$ Mn), 2014–2024
4.4.2. Global Thrombin complex Market Revenue, (US$ Mn), 2014–2024
4.4.3. Global Fibrin complex Market Revenue, (US$ Mn), 2014–2024
4.4.4. Global Synthetic Sealants Market Revenue, (US$ Mn), 2014–2024

5. Global Hemostasis Products Market Revenue (US$ Mn), by End-user, 2014–2024
5.1. Overview
5.2. Global Hospital Market Revenue, (US$ Mn), 2014–2024
5.3. Global Clinic Market Revenue, (US$ Mn), 2014–2024

6. Global Hemostasis Products Market Revenue (US$ Mn), by Application, 2014–2024
6.1. Overview
6.2. Global Trauma Market Revenue, (US$ Mn), 2014–2024
6.3. Global Surgery Market Revenue, (US$ Mn), 2014–2024
6.4. Global Hemophilia Market Revenue, (US$ Mn), 2014–2024
6.5. Global Myocardial Infarction Market Revenue, (US$ Mn), 2014–2024
6.6. Global Stroke Market Revenue, (US$ Mn), 2014–2024
6.7. Global Thrombosis Market Revenue, (US$ Mn), 2014–2024

7. Global Hemostasis Products Market Revenue (US$ Mn), by Geography, 2014–2024
7.1. Overview
7.2. Global Hemostasis Products Market : by Geography, 2014–2024 (US$ Mn)
7.3. North America
7.3.1. North America Hemostasis Products Market Revenue (US$ Mn), by Country, 2014–2024
7.3.1.1. U.S.
7.3.1.2. Canada
7.3.2. North America Hemostasis Products Market Revenue (US$ Mn), by Product type, 2014–2024
7.3.2.1. Topical Hemostats
7.3.2.2. Infusible Hemostats
7.3.2.3. Advanced Hemostats
7.3.3. North America Hemostasis Products Market Revenue (US$ Mn), by End-user, 2014–2024
7.3.3.1. Hospitals
7.3.3.2. Clinics
7.4. Europe
7.4.1. Europe Hemostasis Products Market Revenue (US$ Mn), by Country, 2014–2024
7.4.1.1. U.K.
7.4.1.2. Germany
7.4.1.3. Rest of Europe
7.4.2. Europe Hemostasis Products Market Revenue (US$ Mn), by Product type, 2014–2024
7.4.2.1. Topical Hemostats
7.4.2.2. Infusible Hemostats
7.4.2.3. Advanced Hemostats
7.4.3. Europe Hemostasis Products Market Revenue (US$ Mn), by End-user, 2014–2024
7.4.3.1. Hospitals
7.4.3.2. Clinics
7.5. Asia Pacific
7.5.1. Asia Pacific Hemostasis Products Market Revenue (US$ Mn), by Country, 2014–2024
7.5.1.1. China
7.5.1.2. Japan
7.5.1.3. Rest of APAC
7.5.2. Asia Pacific Hemostasis Products Market Revenue (US$ Mn), by Product type, 2014–2024
7.5.2.1. Topical Hemostats
7.5.2.2. Infusible Hemostats
7.5.2.3. Advanced Hemostats
7.5.3. Asia Pacific Hemostasis Products Market Revenue (US$ Mn), by End-user, 2014–2024
7.5.3.1. Hospitals
7.5.3.2. Clinics
7.6. Latin America
7.6.1. Latin America Hemostasis Products Market Revenue (US$ Mn), by Country, 2014–2024
7.6.1.1. Brazil
7.6.1.2. Mexico
7.6.1.3. Rest of LATAM
7.6.2. Latin America Hemostasis Products Market Revenue (US$ Mn), by Product type, 2014–2024
7.6.2.1. Topical Hemostats
7.6.2.2. Infusible Hemostats
7.6.2.3. Advanced Hemostats
7.6.3. Latin America Hemostasis Products Market Revenue (US$ Mn), by End-user, 2014–2024
7.6.3.1. Hospitals
7.6.3.2. Clinics
7.7. Rest of the World
7.7.1. Rest of the World Hemostasis Products Market Revenue, (US$ Mn), 2014–2024
7.7.2. Rest of the World Hemostasis Products Market Revenue (US$ Mn), by Product type, 2014–2024
7.7.2.1. Topical Hemostats
7.7.2.2. Infusible Hemostats
7.7.2.3. Advanced Hemostats
7.7.3. Rest of the World Hemostasis Products Market Revenue (US$ Mn), by End-user, 2014–2024
7.7.3.1. Hospitals
7.7.3.2. Clinics

8. Company Profiles
8.1. Abbott Laboratories
8.1.1. Company Details
8.1.2. Business Overview
8.1.3. Product Portfolio
8.1.4. Financial Overview
8.1.5. Business Strategies
8.1.6. Recent Developments
8.2. Baxter International, Inc.
8.2.1. Company Details
8.2.2. Business Overview
8.2.3. Product Portfolio
8.2.4. Financial Overview
8.2.5. Business Strategies
8.2.6. Recent Developments
8.3. C. R. Bard, Inc.
8.3.1. Company Details
8.3.2. Business Overview
8.3.3. Product Portfolio
8.3.4. Financial Overview
8.3.5. Business Strategies
8.3.6. Recent Developments
8.4. CSL Behring LLC
8.4.1. Company Details
8.4.2. Business Overview
8.4.3. Product Portfolio
8.4.4. Financial Overview
8.4.5. Business Strategies
8.4.6. Recent Developments
8.5. Grifols, S.A.
8.5.1. Company Details
8.5.2. Business Overview
8.5.3. Product Portfolio
8.5.4. Financial Overview
8.5.5. Business Strategies
8.5.6. Recent Developments
8.6. HemCon Medical Technologies, Inc.
8.6.1. Company Details
8.6.2. Business Overview
8.6.3. Product Portfolio
8.6.4. Financial Overview
8.6.5. Business Strategies
8.6.6. Recent Developments
8.7. Integra LifeSciences Corporation
8.7.1. Company Details
8.7.2. Business Overview
8.7.3. Product Portfolio
8.7.4. Financial Overview
8.7.5. Business Strategies
8.7.6. Recent Developments
8.8. Johnson & Johnson
8.8.1. Company Details
8.8.2. Business Overview
8.8.3. Product Portfolio
8.8.4. Financial Overview
8.8.5. Business Strategies
8.8.6. Recent Developments
8.9. Medtronic plc
8.9.1. Company Details
8.9.2. Business Overview
8.9.3. Product Portfolio
8.9.4. Financial Overview
8.9.5. Business Strategies
8.9.6. Recent Developments
8.10. Pfizer, Inc.
8.10.1. Company Details
8.10.2. Business Overview
8.10.3. Product Portfolio
8.10.4. Financial Overview
8.10.5. Business Strategies
8.10.6. Recent Developments

List of Figures

FIG. 1 Hemostasis Products Market Segmentation
FIG. 2 Global Hemostasis Products Market Revenue, by Product type, 2015 and 2024 (Value %)
FIG. 3 Global Hemostasis Products Market Revenue, by Geography, 2015 (Value %)
FIG. 4 Global Hemostasis Products Market Revenue, by Geography, 2024 (Value %)
FIG. 5 Market Attractiveness Analysis: Global Hemostasis Products Market, by Geography, 2014
FIG. 6 Global Hemostasis Products Market: Market Share Analysis, By Key Players, 2015 (Value %)
FIG. 7 Global Collagen Market Revenue, (US$ Mn), 2014–2024
FIG. 8 Global Oxidized Regenerated Cellulose Market Revenue, (US$ Mn), 2014–2024
FIG. 9 Global Gelatin Market Revenue, (US$ Mn), 2014–2024
FIG. 10 Global Polysaccharide Market Revenue, (US$ Mn), 2014–2024
FIG. 11 Global Fresh Frozen Plasma Market Revenue, (US$ Mn), 2014–2024
FIG. 12 Global Platelet concentrate from donor Market Revenue, (US$ Mn), 2014–2024
FIG. 13 Global Factor VIII from blood Market Revenue, (US$ Mn), 2014–2024
FIG. 14 Global Prothrombin Complex Market Revenue, (US$ Mn), 2014–2024
FIG. 15 Global Flowable Complex Market Revenue, (US$ Mn), 2014–2024
FIG. 16 Global Thrombin Complex Market Revenue, (US$ Mn), 2014–2024
FIG. 17 Global Fibrin Complex Market Revenue, (US$ Mn), 2014–2024
FIG. 18 Global Synthetic Sealants Market Revenue, (US$ Mn), 2014–2024
FIG. 19 Global Hospitals Market Revenue, (US$ Mn), 2014–2024
FIG. 20 Global Clinics Market Revenue, (US$ Mn), 2014–2024
FIG. 21 Global Trauma Market Revenue, (US$ Mn), 2014–2024
FIG. 22 Global Surgery Market Revenue, (US$ Mn), 2014–2024
FIG. 23 Global Hemophilia Market Revenue, (US$ Mn), 2014–2024
FIG. 24 Global Myocardial Infarction Market Revenue, (US$ Mn), 2014–2024
FIG. 25 Global Stroke Market Revenue, (US$ Mn), 2014–2024
FIG. 26 Global Thrombosis Market Revenue, (US$ Mn), 2014–2024
FIG. 27 Rest of the World Hemostasis Products Market Revenue, (US$ Mn), 2014–2024
FIG. 28 Abbott Laboratories: Financial Overview (US$ Mn), 2013–2015
FIG. 29 Baxter International, Inc.: Financial Overview (US$ Mn), 2013–2015
FIG. 30 C. R. Bard, Inc.: Financial Overview (US$ Mn), 2013–2015
FIG. 31 CSL Behring LLC: Financial Overview (US$ Mn), 2013–2015
FIG. 32 Grifols, S.A.: Financial Overview (US$ Mn), 2013–2015
FIG. 33 Integra LifeSciences Corporation: Financial Overview (US$ Mn), 2013–2015
FIG. 34 Johnson & Johnson Group of Companies: Financial Overview (US$ Mn), 2013–2015
FIG. 35 Medtronic plc: Financial Overview (US$ Mn), 2013–2015
FIG. 36 Pfizer, Inc.: Financial Overview (US$ Mn), 2013–2015

List of Tables

TABLE 1 Market Snapshot: Global Hemostasis Products Market
TABLE 2 Global Hemostasis Products Market Revenue, by Product type, (US$ Mn), 2014–2024
TABLE 3 Global Topical Hemostasis Product Market Revenue, by Product type, (US$ Mn), 2014–2024
TABLE 4 Global Infusible Hemostasis Product Revenue, by Product type, (US$ Mn), 2014–2024
TABLE 5 Global Advanced Hemostasis Product Market Revenue, by Product type, (US$ Mn), 2014–2024
TABLE 6 Global Hemostasis Products Market, by End user, (US$ Mn), 2014–2024
TABLE 7 Global Hemostasis Products Market Revenue, by Application, (US$ Mn), 2014–2024
TABLE 8 Global Hemostasis Products Market, by Geography, (US$ Mn), 2014–2024
TABLE 9 North America Hemostasis Products Market Revenue, by Country, (US$ Mn), 2014–2024
TABLE 10 North America Hemostasis Products Market Revenue, by Product type, (US$ Mn), 2014–2024
TABLE 11 North America Hemostasis Products Market Revenue, by End user, (US$ Mn), 2014–2024
TABLE 12 Europe Hemostasis Products Market Revenue, by Country, (US$ Mn), 2014–2024
TABLE 13 Europe Hemostasis Products Market Revenue, by Product type, (US$ Mn), 2014–2024
TABLE 14 Europe Hemostasis Products Market Revenue, by End user, (US$ Mn), 2014–2024
TABLE 15 Asia Pacific Hemostasis Products Market Revenue, by Country, (US$ Mn), 2014–2024
TABLE 16 Asia Pacific Hemostasis Products Market Revenue, by Product type, (US$ Mn), 2014–2024
TABLE 17 Asia Pacific Hemostasis Products Market Revenue, by End user, (US$ Mn), 2014–2024
TABLE 18 Latin America Hemostasis Products Market Revenue, by Country, (US$ Mn), 2016–2024
TABLE 19 Latin America Hemostasis Products Market Revenue, by Product type, (US$ Mn), 2014–2024
TABLE 20 Latin America Hemostasis Products Market Revenue, by End user, (US$ Mn), 2014–2024
TABLE 21 Rest of the World Hemostasis Products Market Revenue, by Product type, (US$ Mn), 2014–2024
TABLE 22 Rest of the World Hemostasis Products Market Revenue, by End user, (US$ Mn), 2014–2024



【レポートのキーワード】

止血製品、コラーゲン、酸化再生セルロース、新鮮凍結血漿、トロンビン複合体

★調査レポート[止血製品の世界市場:産業分析、市場規模、市場シェア、成長、動向、予測]販売に関する免責事項
★調査レポート[止血製品の世界市場:産業分析、市場規模、市場シェア、成長、動向、予測]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆